Showing results (71-80 of 5,223) with videos related to
Sort By:
Pageof 523
Current Pharmaceutical Design|November 1, 2006
Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticalsKenji Hashimoto, Kiichi IshiwataNeuropsychopharmacology Reports|August 20, 2020
Decreased bone mineral density in ovariectomized mice is ameliorated after subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamineYuko Fujita, Kenji HashimotoThe Open Medicinal Chemistry Journal|January 21, 2011
α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's DiseaseJun Toyohara, Kenji HashimotoThe European Journal of Neuroscience|January 20, 2006
Slow oscillatory activity of rat globus pallidus neurons in vitroKenji Hashimoto, Hitoshi KitaNihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|March 29, 2002
[Glutamate hypothesis of schizophrenia and targets for new antipsychotic drugs]Kenji Hashimoto, Masaomi IyoPlos One|February 8, 2019
Impact of consuming green and yellow vegetables on the depressive symptoms of junior and senior high school students in JapanMami Tanaka, Kenji HashimotoAnnals of General Psychiatry|March 9, 2010
Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptorsTsutomu Furuse, Kenji HashimotoPsychiatry Investigation|January 30, 2014
Benefical effects of sigma-1 agonist fluvoxamine for tardive dyskinesia and tardive akathisia in patients with schizophrenia: report of three casesYakup Albayrak, Kenji HashimotoAsian Journal of Psychiatry|October 4, 2024
Therapeutic potential of ketamine in management of epilepsy: Clinical implications and mechanistic insightsYunfei Tan, Kenji HashimotoPageof 523